Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

The proline-rich acidic protein is epigenetically regulated and inhibits growth of cancer cell lines.

Zhang J, Wong H, Ramanan S, Cheong D, Leong A, Hooi SC.

Cancer Res. 2003 Oct 15;63(20):6658-65.

2.

DRO1, a gene down-regulated by oncogenes, mediates growth inhibition in colon and pancreatic cancer cells.

Bommer GT, Jäger C, Dürr EM, Baehs S, Eichhorst ST, Brabletz T, Hu G, Fröhlich T, Arnold G, Kress DC, Göke B, Fearon ER, Kolligs FT.

J Biol Chem. 2005 Mar 4;280(9):7962-75.

4.

Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.

Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y.

Oncogene. 2005 Nov 24;24(53):7946-52.

PMID:
16007117
5.

Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma.

Chen J, Xu J, Ying K, Cao G, Hu G, Wang L, Luo C, Lou M, Mao Y, Xie Y, Lu Y.

Gene. 2004 Sep 29;340(1):61-9.

PMID:
15556295
6.
7.

CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines.

Shao L, Cui Y, Li H, Liu Y, Zhao H, Wang Y, Zhang Y, Ng KM, Han W, Ma D, Tao Q.

Clin Cancer Res. 2007 Oct 1;13(19):5756-62. Erratum in: Clin Cancer Res. 2007 Nov 1;13(21):6543.

8.
9.

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.

Wolf I, O'Kelly J, Rubinek T, Tong M, Nguyen A, Lin BT, Tai HH, Karlan BY, Koeffler HP.

Cancer Res. 2006 Aug 1;66(15):7818-23.

10.

Mechanistic study on growth suppression and apoptosis induction by targeting hepatoma-derived growth factor in human hepatocellular carcinoma HepG2 cells.

Tsang TY, Tang WY, Tsang WP, Co NN, Kong SK, Kwok TT.

Cell Physiol Biochem. 2009;24(3-4):253-62. doi: 10.1159/000233250.

11.

[Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].

Xu JY, Chen LB, Xu JY, Yang Z, Wei HY, Xu RH.

Ai Zheng. 2006 May;25(5):526-32. Chinese.

PMID:
16687068
12.
13.
14.

Overexpression of the signal peptide whirlin isoform 2 is related to disease progression in colorectal cancer patients.

Toiyama Y, Mizoguchi A, Kimura K, Hiro J, Tutsumi T, Inoue Y, Miki C, Kusunoki M.

Int J Oncol. 2009 Oct;35(4):709-15.

PMID:
19724906
15.

Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.

Ushio K, Hashimoto T, Kitamura N, Tanaka T.

Mol Cancer Res. 2009 Jul;7(7):1179-88. doi: 10.1158/1541-7786.MCR-08-0289.

16.

Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response.

Feng P, Wang B, Ren EC.

Int J Biochem Cell Biol. 2008;40(1):98-109.

PMID:
17698398
17.

A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.

Pampalakis G, Prosnikli E, Agalioti T, Vlahou A, Zoumpourlis V, Sotiropoulou G.

Cancer Res. 2009 May 1;69(9):3779-87. doi: 10.1158/0008-5472.CAN-08-1976.

18.
19.

RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.

Xue WJ, Li C, Zhou XJ, Guan HG, Qin L, Li P, Wang ZW, Qian HX.

J Gastroenterol Hepatol. 2008 Sep;23(9):1448-58.

PMID:
17683489
20.

14-3-3sigma is down-regulated in human prostate cancer.

Urano T, Takahashi S, Suzuki T, Fujimura T, Fujita M, Kumagai J, Horie-Inoue K, Sasano H, Kitamura T, Ouchi Y, Inoue S.

Biochem Biophys Res Commun. 2004 Jul 2;319(3):795-800.

PMID:
15184053
Items per page

Supplemental Content

Support Center